Everest Medicines commissions mRNA vaccine production plant in Jiashan
Everest Medicines, a China-based biopharmaceutical company, has commenced operations at its mRNA vaccine production plant in Jiashan, Zhejiang Province, thereby becoming a fully-integrated biopharma. With the first phase going live, Everest Medicines now owns complete pharmaceutical and vaccine value chain from discovery, clinical development, manufacturing, and commercialization. The first phase of the vaccine manufacturing facility […]